In conclusion, our study uncovered the crucial role of E2F1/CKS2/PTEN signaling axis in regulating malignant phenotypes of RB and CKS2 might become a novel therapeutic target for RB in the future. The gene discussed is E2F1; the disease is retinoblastoma.